Literature DB >> 19744251

Assessment of the progression of haemophilic arthropathy in children.

H Pergantou1, H Platokouki, G Matsinos, O Papakonstantinou, A Papadopoulos, P Xafaki, D Petratos, S Aronis.   

Abstract

Arthropathy is considered as an irreversible and progressive complication in patients with haemophilia, even in children on prophylaxis. To estimate the progression of haemophilic arthropathy, 85 joints of 24 boys with severe (n = 18) and moderate (n = 6) haemophilia (A: 22, B: 2) were investigated with clinical examination, X-rays and magnetic resonance imaging (MRI) at two time periods (time 0 and 1). Patients' age at time 0 was 10.5 +/- 3.6 years and time elapsed to time 1 was 3.8 +/- 1.4 years. At time 0: all investigated joints had more than three bleeds. Sixteen boys were on secondary prophylaxis for 5.4 +/- 2.8 years. Clinical score (a modification of World Federation of Haemophilia's scale): 2.0 +/- 3.6, X-ray score (Pettersson): 2.1 +/- 2.8, MRI score (Denver): 4.5 +/- 3.8. After the first evaluation, prophylaxis was intensified in 11 children and initiated in four. At time 1: clinical score: 1.5 +/- 3.1, X-ray: 1.7 +/- 2.7, MRI score: 5.1 +/- 4.1. On average, the clinical and X-ray scores showed a significant improvement (26% and 40% of the joints respectively, P < 0.01) and the number of haemarthroses evidenced a threefold reduction from time 0 to 1 (P < 0.01), findings that could be associated with the modification of prophylaxis after time 0. MRI findings showed deterioration in 34% of the joints. Conversely, 14 joints (16.5%) with mild or moderate synovitis without cartilage degradation at time 0 showed an improvement at time 1. The information carried by the three scales could be divided into information shared by the three scores and information specific to each score, thus giving a more complete picture of joint damage caused by bleedings.

Entities:  

Mesh:

Year:  2009        PMID: 19744251     DOI: 10.1111/j.1365-2516.2009.02109.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  8 in total

1.  MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia.

Authors:  Wouter Foppen; Irene C van der Schaaf; Frederik J A Beek; Willem P T M Mali; Kathelijn Fischer
Journal:  Blood Adv       Date:  2020-01-14

2.  T2 mapping in the quantitative evaluation of articular cartilage changes in children with hemophilia: A pilot study.

Authors:  Ningning Zhang; Yanqiu Lv; Yue Liu; Guangheng Yin; Di Hu; Runhui Wu; Yun Peng
Journal:  Pediatr Investig       Date:  2019-01-08

3.  Clinical and functional evaluation of the joint status of hemophiliac adults at a Brazilian blood center.

Authors:  Adriana Aparecida Ferreira; Maria Teresa Bustamante-Teixeira; Isabel Cristina Gonçalves Leite; Camila Soares Lima Corrêa; Daniela de Oliveira Werneck Rodrigues; Danielle Teles da Cruz
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 4.  Merging into the mainstream: the evolution of the role of point-of-care musculoskeletal ultrasound in hemophilia.

Authors:  Nihal Bakeer; Amy D Shapiro
Journal:  F1000Res       Date:  2019-07-09

5.  Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study.

Authors:  Jennifer Stimec; Saunya Dover; Eleanor Pullenayegum; Victor S Blanchette; Andrea S Doria; Brian M Feldman; Manuel Carcao; Georges E Rivard; Sara J Israels; Anthony K Chan; MacGregor Steele; Stephanie Cloutier; Robert J Klaassen; Victoria E Price; Roona Sinha; Nicole Laferriere; Elizabeth Paradis; John K M Wu; Paul Babyn
Journal:  Res Pract Thromb Haemost       Date:  2021-10-16

Review 6.  Hemophilia A in Brazil - epidemiology and treatment developments.

Authors:  Adriana Aparecida Ferreira; Isabel Cristina Gonçalves Leite; Maria Teresa Bustamante-Teixeira; Maximiliano Ribeiro Guerra
Journal:  J Blood Med       Date:  2014-09-23

7.  Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand.

Authors:  J Oldenburg; R Zimmermann; O Katsarou; G Theodossiades; E Zanon; B Niemann; E Kellermann; B Lundin
Journal:  Haemophilia       Date:  2014-12-02       Impact factor: 4.263

8.  Protocol for a feasibility randomised controlled trial of a musculoskeletal exercise intervention versus usual care for children with haemophilia.

Authors:  Ferhana Hashem; Melanie Bladen; Liz Carroll; Charlene Dodd; Wendy I Drechsler; David Lowery; Vishal Patel; T Pellatt-Higgins; Eirini Saloniki; David Stephensen
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.